Status: current, Defined. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4556306012 | Product containing precisely fremanezumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4556307015 | Fremanezumab 150 mg/mL solution for injection | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fremanezumab 150 mg/mL solution for injection | Has manufactured dose form | Solution for injection | true | Inferred relationship | Some | ||
| Fremanezumab 150 mg/mL solution for injection | Is a | Fremanezumab only product in parenteral dose form | true | Inferred relationship | Some | ||
| Fremanezumab 150 mg/mL solution for injection | Has precise active ingredient | Fremanezumab | true | Inferred relationship | Some | 1 | |
| Fremanezumab 150 mg/mL solution for injection | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Fremanezumab 150 mg/mL solution for injection | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Fremanezumab 150 mg/mL solution for injection | Has BoSS | Fremanezumab | true | Inferred relationship | Some | 1 | |
| Fremanezumab 150 mg/mL solution for injection | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR